Gilead Antisense Patent Estate

Foster City, California
United States,

Gilead Antisense Patent Estate provides patent applications covering a broad proprietary suite of antisense chemistry and antisense drug delivery systems.

Gilead Antisense Patent Estate was acquired by Isis Pharmaceuticals on December 18, 1998.

Join Mergr to view all 13 acquisitions of life science companies in 1998, including 3 acquisitions by private equity firms, and 10 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 24 in number of deals in 1998. The largest life science acquisition in 1998 was Penederm - which was acquired by Mylan Laboratories for $205M.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Gilead Antisense Patent Estate.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 120K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.